Recurrent ketoacidosis: Is it a ketone metabolism disorder?
dc.contributor.author | Canda, Ebru | |
dc.contributor.author | Yazici, Havva | |
dc.contributor.author | Esra, E. R. | |
dc.contributor.author | Kalkan Ucar, Sema | |
dc.contributor.author | Gemperle-Britschgi, Corinne | |
dc.contributor.author | Habif, Sara | |
dc.contributor.author | Onay, Huseyin | |
dc.contributor.author | Sass, Jorn Oliver | |
dc.contributor.author | Coker, Mahmut | |
dc.date.accessioned | 2019-10-27T10:45:28Z | |
dc.date.available | 2019-10-27T10:45:28Z | |
dc.date.issued | 2018 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Objective: Two defects of ketogenesis have been reported in the human so far; mitochondria) 3-hydroxy-3-methyl glutaryl CoA synthase (Mhs) and 3-hydroxymethyl-3glutaryl CoA lyase (HL) deficiencies. Defects of ketone degradation (ketolysis) can be the result of enzyme deficiency of succinyl CoA: 3 oxoacid CoA transferase (SCOT) or methylacetoacetyl CoA thiolase-beta ketothiolase (MAT). Our aim was to evaluate the clinical and laboratory findings of patients who were followed up with the diagnosis of ketone metabolism disorders. Methods: Patients who were diagnosed with ketone metabolism disorders were examined retrospectively. Results: The patients had HL deficiency (n=4), MAT deficiency (n=3) and SCOT deficiency (n=2). The median age of the patients was 5 years (6 months-15.5 years) and the mean age of the first metabolic decompensation episode was 7.7 months (22 days19 months). A patient with MAT deficiency was asymptomatic and diagnosed by family screening. Two patient; developed severe neurological deficit like spastic tetraparesis. It was seen that decompensation attacks developed after poor feeding, vomiting and infections such as gastroenteritis. Conclusion: in case of unexplained metabolic acidosis attacks, ketone metabolism disorders should be kept in mind. Acute decompensation may occur at different ages, and its clinical severity may be variable. Early diagnosis and appropriate treatment are very important in terms of mortality and morbidity. | en_US |
dc.identifier.doi | 10.5222/buchd.2018.115 | |
dc.identifier.endpage | 121 | en_US |
dc.identifier.issn | 2146-2372 | |
dc.identifier.issn | 1309-9566 | |
dc.identifier.issn | 2146-2372 | en_US |
dc.identifier.issn | 1309-9566 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 115 | en_US |
dc.identifier.uri | https://doi.org/10.5222/buchd.2018.115 | |
dc.identifier.uri | https://hdl.handle.net/11454/31152 | |
dc.identifier.volume | 8 | en_US |
dc.identifier.wos | WOS:000440521200006 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | tr | en_US |
dc.publisher | Dr Behcet Uz Cocuk Hastaliklari Ve Cerrahisi | en_US |
dc.relation.ispartof | Izmir Dr Behcet Uz Cocuk Hastanesi Dergisi | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Ketoacidosis | en_US |
dc.subject | ketogenesis defects | en_US |
dc.subject | ketolysis defect | en_US |
dc.title | Recurrent ketoacidosis: Is it a ketone metabolism disorder? | en_US |
dc.type | Article | en_US |